European markets close mixed; Novo Nordisk shares jump 9%, extending rally after GLP-1 pill approval – CNBC
European markets close mixed; Novo Nordisk shares jump 9%, extending rally after GLP-1 pill approval CNBC European shares close at fresh record high as Novo Nordisk drives healthcare boost Reuters European market rebound led by pharma gains; STOXX 600 logs new record high (EUR:USD) Seeking Alpha Stock market today, December 23: Novo Nordisk’s promotion dominates Europe. Fincantieri rebounds […]
NVO’s First Oral Obesity Pill Approval: What Does it Mean for Lilly?
Earlier this week, the FDA approved Eli Lilly and Company’s LLY rival Novo Nordisk’s NVO oral version of the obesity drug Wegovy (semaglutide). Wegovy is the first oral GLP-1 drug to be approved in the United States, ushering in a new era of obesity treatment. The Wegovy pill includes the same active ingredient — semaglutide — contained […]
Incretin Therapies After Bariatric Surgery Linked to Lower Risk of Alcohol Disorder
(MedPage Today) — Treatment with incretin-based weight-loss medications, like GLP-1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation of medications for AUD compared…
The Wegovy weight loss pill could come to Canada. What we know
The FDA approved the one-a-day Wegovy pill, the first oral GLP-1 medication for obesity in the U.S., Wegovy manufacturer Novo Nordisk said in a statement Tuesday.
PFE’s Oncology & Obesity Pipeline Position It for Post-LOE Growth
Pfizer PFE expects a significant negative impact on revenues from the loss of exclusivity (“LOE”) of several of its key products in the 2026-2030 period. These include Eliquis, Vyndaqel, Ibrance, Xeljanz and Xtandi, all of which face patent expirations. However, the company has strengthened its R&D pipeline through M&A deals, successful data readouts and pivotal program […]
New species are being discovered faster than ever before
New species are now being discovered faster than ever before, a new study suggests. About 300 years ago, Swedish naturalist Carl Linnaeus set out on a bold quest: to identify and name every living organism on Earth. Now celebrated as the father of modern taxonomy, he developed the binomial naming system and described more than […]
Two New Developments May Help Future Plaintiffs Compel GLP-1 Coverage
Two recent developments may potentially increase GLP-1 coverage for more patients with obesity. The lack of coverage may be another failure of recognizing obesity as a chronic disease. Medscape Diabetes & Endocrinology
US regulators approve Wegovy pill, first oral medication to treat obesity – The Guardian
US regulators approve Wegovy pill, first oral medication to treat obesity The Guardian With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins CNN Weight-loss pill approval set to accelerate food industry product overhauls Reuters Novo Nordisk stock surges on hopes Wegovy pill approval will deliver ‘redemption’ for investors CNBC F.D.A. Approves Wegovy Weight-Loss […]
Novo Nordisk’s new obesity pill, Alphabet’s data center deal, the end of EV euphoria and more in Morning Squawk – CNBC
Novo Nordisk’s new obesity pill, Alphabet’s data center deal, the end of EV euphoria and more in Morning Squawk CNBC With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins CNN Novo Nordisk stock surges on hopes Wegovy pill approval will deliver ‘redemption’ for investors CNBC FDA Okays Oral Semaglutide 25 mg for […]
The K-shaped economy is carrying a ticking time bomb into 2026
The GDP number arrived just before Christmas, wrapped like good news. The U.S. economy grew at a 4.3% annual rate in the third quarter, blowing past economists’ expectations and delivering the kind of headline that signals strength heading into the new year. Consumers went on an unusually strong spending tear while corporations cinched $166 billion […]